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In patients with left ventricular dysfunction associated with 
coronary artery disease, myocardial viability is an important 
determinant of management and prognosis. If viable myocytes 
are present within a myocardial region that is dysfunctional 
because of severe ischemia at rest, restoration of blood tlow to 
the region by coronary revascularization can potentially re- 
verse the contractile dysfunction. If a signitkant amount of 
such ischemic viable dysfunctional myocardium is present, 
revascularimtion can lead to an improvement in regional and 
possibly, global left ventricular function (1). 
Positron emission tomography is currently the most sensi- 
tive imaging modality available for identifying myocardial 
viability (2). It measures regional myocardiai metabolism, 
which reflects the presence and extent of viable tissue. These 
data are correlated with perfusion data that localize ischemia 
at rest. Recently, the presence of contractile reserve as dem- 
onstrated by improved function after infusion of a low dose 
of dobutamine has been proposed to be another useful marker 
of myocardial viability (3-6). With advztces in the technol- 
ogy of digital image acquisit:on, improved regional contra&e 
function can be detected by echocardiogiaphy. a potentiahy 
simpler, cost-effective and widely available technique. The 
purpose of this study was to evaluate low dose dobutamine 
echocardiography in a cohort of patients with chronic ischemic 
left ventricular dysfunction and to correlate the presence of 
dobutamine-induced o&a&e reserve with the findings of 
positron emission tomography. 
Study p&s~ts. The study group comprised 60 consecutive 
patients in clinically stable condition who had angiographicalIy 
significant cmo~ry army disease (debned as the presence of 
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at least one lumen diamiter stenosis 275% in a major 
epicardial coronary artery) with impaired left ventricular sys- 
tolic function and were being considered for revascularization. 
Patients with acute ischemic events including myocardial in- 
farction and hospital admission for unstable angina within 4 
weeks of the study were specifically excluded. Left ventricular 
systolic function was determined with radionuclide ventricu- 
lography. All patients underwent positron emission tomogra- 
phy and low dose dobutamine echocardiography to assess 
myocardial viability. The study was approved by the Human 
Research Ethics Committee of our institution; informed con- 
sent was obtained from all patients before the investigations. 
DoLmtamine infusion. Dobutamine was infused intrave- 
nously in a solution of 5% dextrose through a peripheral arm 
vein, commencing at a dose of 5 rgikg body weight per min. 
After 3 min, the infusion rate was increased to 10 @kg per 
min and continued for 3 additional min. The infusion was 
terminated at the end of this stage in 30 patients: it was 
continued in the other 30 patients, who underwent a maximal 
dose dobutamine stress test. The findings during the higher 
dose stages (primarily for the detection of ischemia) were not 
analyzed in this study, which only examined the responses up 
to the end of infusion of 10 @kg per min. Throughout the 
infusion, a three-lead electrocardiogram (ECG) was continu- 
ously monitored. Upper arm blood pressure was measured at 
the end of each dose interval. 
Predetermined end points of the study included systemic 
hypertension (defined as systolic blood pressure 2220 mm Hg 
or diastolic blood pressure 2120 mm Hg, or both), hypoten- 
sinn (defined as a systolic reading 580 mm Hg or a decrease in 
systolic blood pressure ~30 mm Hg from baseline, or both), 
development of angina or kchemic ECG changes (defined as 
flat or downsloping ST segment depression ~2 mm from 
baseline) and significant cardiac arrhythmia. 
hboeardiographic imaging and analysis. Before the start 
of dobutamine infusion, a complete baseline two-dimensional 
transthoracic echocardiographic and Doppler assessment was 
performed with the use of a commercially available scanner 
(XP128/1Oc, Acuson) interfaced with a digital image acquisi- 
tion computer (Cineview, Tomtec Imaging Systems) that was 
programmed to capture eight ‘frames of ECG-gated echocar- 
diographic images of the systolic phase at 60-msc iKt-rvals. 
Images in the parastemal long- and short-axis and apical four- 
and hvo-chamber views were acquired before the start of 
dobutamine infusion and at the end of thd5- and &.&kg per 
min stages. 
After acquisition, echocardiograbhic images were reviewed 
by using the image acquisition computer, which displayed 
images in a quad-screen, tine-loop playback format. Identical 
left ventricular segments at rest and during administration of 
5 and 10 &kg per min of dobutamine, were analyzed for 
regional wail motion with use of a standard 16 segment model 
(7) by two experienced obseners who had no knowledge of the 
positrrm emission tomographic findings 3r clinical details. 
Differences in interpretation were resolved by consensus. By 
visual assessment of endocardial motion and wall thickening, 
wall motion in each segment was classified as normal, bypoki- 
netic, akinetic br dyskinetic, each carrying a wall motion score 
of 1. 2, 3 or 4, respectively. The left ventricular wall motion 
score index was calculated as the ratio between the sum of all 
available segmental wall motion scores and the number of 
segments visualized. 
Regional wall motion during the rest echocardiographic 
study was analyzed, and left ventricular segments were broadly 
categorized as normal or dysfunctional. The latter category 
included segments that were hypokinetic, akinetic or dyski- 
netic. Dobutamine-induced contractile reserve in a dysfunc- 
tional segment at rest was defined as an improvement in the 
wall motion score of that segment during either stage of the 
dobutamine infusion by one or more grades in comparison 
with the baseline score. Deterioration in regional wall motion 
was defined as worsening in wall motion score by one or more 
grades in comparison with the previous stage. A biphasic 
response to dobutamine was defined as improvement in wall 
motion at low doses followed by worsening at higher doses. 
Interobserver and intraobserver agreement on wall motion 
score was 92% and 94%, respectively. 
Positron emission tomography. Radiopharmaceuticals 
were prepared in-house by cyclotron (IBA, 10/5) and radio- 
chemistry facilities. Nitrogen-13 (N-13) ammonia and fluorine-18 
(F-18) fluorodeoxyglucose were utilized as a perfusion and 
metabolic tracer, respectively. Emission data were acquired by 
a whole body positron emission tomographic scanner @CAT 
951, Siemens) that allowed simultaneous imaging of 31 trans- 
axial slices with a IO&cm field of view. All patients were 
studied in the postprandial rest staie and received 50 gm of 
oral glucose loading before imaging. Capillary blood glucose 
levels were monitored by a glucometer (Accutrend, Bochr- 
inger Mannheim) before and during image acquisition; if the 
levels were elevated, intravenous insulin was administered 
according to a sliding scale. 
A transmission scan of the thorax was first acquired to 
define the position of the heart and to allow subsequent at- 
tenuation correction of the emission data. At the completion of 
the transmission scan, the patient was administered -1,000 
MBq of N-13 ammonia intravenously, after which data were 
acquired for 20 min. Then -350 MBq of F-18 fluorodeoxyglu- 
case was administered intravenously and after a 40-min uptake 
period, data were acquired for 30 min. Care was taken to 
ensure that patient position was constant within the scanner 
for the full duration of the study. On completion of tomo- 
graphic data acquisition, the images were reconstructed and 
correction was made for variable soft tissue attenuation. F-18 
fluorodeoxyglucose metabolic images were normalized to the 
corresponding perfusion images, using the region with the 
maximal N-13 ammonia uptake as the reference region. 
The positron emission tomographic images were inter- 
pretcd by two experienced observers who had no knowledge of 
the echocardiographic findings or clinical details. In cases of 
disagreement, the studies were reviewed and a consensus was 
reached. The left ventricle was divided using the &segment 
model (7), and N-13 ammonia and F-18 fluorodeoxyglucose 
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Table 1. Semiquantitative Grading of Relative Uptake of 
Nitrogen-I3 Ammonia and Fluorine-18 Fluorodeoxyglucose on 
Positron Emission Tomography 
Gmif. Positron Emission Tomographic Tracer Up&e 
100% 2 Uptake > 70% 
70% 2 Uptake > 50% 
50% 2 Uptake > 30% 
30% 2 Uptake r 07c 
uptake were graded with use of the Bronson color map. This 
map color coded left ventricu!ar myocardial segments accord- 
ing to their degree of tracer uptake relative to the region with 
the maximal uptake, with semiquantitatlve division into 10 
percentiles. The N-13 ammonia and F-18 fluorodeoxyglucose 
uptake in each segment were then scored by using the system 
illustrated in Table 1. Interobserver and intraobserver agree- 
ment in tracer uptake grades was 90% and 92%, respectively. 
Nitrogen-13 ammonia and F-18 fluorodeoxyglucose uptake 
in echocardiographically dysfunctional left ventricular seg- 
ments was studied in each patient. Segments with F-18 tluoro- 
deoxyglucose uptake >50% (grade 1 or 2) were defined as 
via!& on positron emission tomography. If a pattern of pcrfu- 
sion-metabolism mismatch (N-13 ammonia uptake grade 
greater than that of F-18 fluorodeoxyglucose by 21) was also 
present, the dysfunctional segment was labeled as viable wirh 
mismarch, indicating well preserved glucose metab+sa in the 
prescz. of relative hypoperfusion. Segments with F-18 fluoro- 
deoxyghicose uptake ~50% (grade 3 or 4) were catc;orized as 
nonvtibk. 
StaSsticai analysis. Values are expressed as nzz value + 
1 SD, when appropriate. Repeated measures analysis of vari- 
ance and the Scheff6 F-test were used to compare hemody- 
.namic variables and echocardiographic wall motion score 
indexes at diierent stages of the dobutamine infusion. The 
Student r test was used to test differences between mean values 
of findings of positron emission tomography and dobutamine 
echocardiography, and also linclmgs of diierent subgroups 
within each imaging modality. (X-square analysis and the 
Fisher exact test were used to compare categoric positron 
emission tomographic and echocardiographic data. Statistical 
significance was indicated by p values < 0.05. 
Results 
The clinical characteristics of the 60 patients are shown in 
Table 2. They underwent dobutamine echocardiography and 
positron emission tomography within a mean interval of 5 2 7 
days of the other investigation; both studies were performed on 
the same day in 24 patients. Radionuclide ventriculography 
was perfomed at a mean intervaf of 10 t 10 days from 
dobutamine echo&rdiography. All patients with a history of 
hypertension had satisfactory blood pressure control by med- 
ications before entering the study. Glualse controI was adequate 
ih diabetic patients during positron emission tomogmphy. 
Table 2. Baseline Characteristics of ihe 60 Study Patients 
Age 07) 
Male 
LVEF on radiorwlide ventriadcgqhy 
Mldtivesscl corcmfy artery dia.. 
Previous myoxdial infarction 
Ahnormal Q waves on ECG 
Angina class (Canadian Cardiovxular So&v) 
I or II 
III CM IV 
Heart failure functkxal class (NW York Heart .&c&ion) 
I or II 
III or IV 
Hypertension 
Diabetes m&us 
IasuIin dependent 
62Z 11 
49’(82%) 
29:10% 
52 (87%) 
47 (78%) 
3.4 (57%) 
39 (65%) 
21(3S%) 
19 (32%) 
41(&l%) 
24(40%) 
IO (16%) 
2 (3%) 
Data are presented as mean value + SD or number I?+) of patients. ECG = 
electrocardiogram; LVEF = left ventricular ejection fraction. 
Hemodpamii responses and tolerance of dubutamiw in- 
t&ii Hemodynamic variables including heart rate, systolic 
blood pressure and systolic pressure-heart rate- double prod- 
uct at baseline berore administration of dobutamine and 
during the two stages of the infusiin are shown in Table 3. At 
the end of the infusion of low dose dobutamine (10 @g per 
min), both tbe mean heart rate and rate-pressure double 
product were significantly higher than at baseline. 
The protocol for infusion of dobutamine was well tolerated 
and successfully completed in all patients. No patiems mani- 
fested any predetermined end point or other sign&ant side 
effect resulting in premature termination of their study. In 
particular, there were no serious rampliitions related to 
dobutamine infusion, including unstable angina, myocardial 
infarction or death. 
Re&oalwaUmotioeatrestanddtuingdaxkmii 
infosiia During rekt echardiography, a complete regional 
wall motion assessment of all left ventricular segments could 
bc performed in 54 patients. In six patient$ part of the leti 
ventricle (1 to 10 segments) could not be adequately assessed 
because of suboptimal images. Wall motion analysis revealed 
11 * 3 dysfunctional segmentipatient. Of the 654 dysfunc- 
Table 3. Hemhamic Variables and Wall Motion Score Index a: 
Baseline and During Dobutamine Infusion 
DobummcInfurn, 
Hehn rate (IxatrJmin) 77 + 14 ‘6 c 1s 83 2 15’t 
Sysrolic blood pr- (mm Hg) 121’20 126+21* 12sz21 
Han nte-symlic blood pressure 85.8 ? 366 88.2 Z 37.6 94.5 Z 39.2*t 
l p c 0.05 vemu bz&ne. tp < O.OS - 5 .ug/kg per mil. Data are 
presemedasme;mvatue~sD. 
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tional segments identified, 256 were hypokinetic, 379 appeared 
akinetic and 19 had dyskinetic wall motion. 
After infusion of 5 j@kg per min of dnhutamine. 52 
patients (87%) showed an improvement in contractile function 
of two to nine segments within dysfunctional myocardium. 
When the infusion rate was increased to 10 @kg per min, 22 
of these 52 patients had inotropic responses in other dysfunc- 
tional regions that had not responded at the lower dose. 
However, in 13 patients, some of the previously observed 
contractile improvement disappeared. presumably because of 
ischemia (biphasic response). At the end of the infusion, eight 
patients had shown no inotropic enhancement, and four of 
these showed some deterioration in wall motion. The mean 
wall motion score indexes of the patient cohort after the 5- and 
IO-@kg per min stages of dobutamine infusion were both 
significantly lower than the baseline score index. Dobutamine- 
induced contractile reserve was present in 47% of segments 
with rest hypokinesia in contrast to 23% of akinetic or dyski- 
netic segments (p = 0.0001). 
All 13 patients with no history of previous myocardial 
infarction showed wall motion improvement during infusion of 
dobutamine, as did 39 of the 47 patients with previous infarc- 
tion (p = NS). In the latter, there were no significant differ- 
ences in inotropic responsiveness to dobutamine in patients 
with or without abnormal Q waves on ECG (29 of 34 vs. 10 of 
13, p = NS). 
Figure 1. Bar graph grouping the study patients according to the 
number of segments of dysfunctional myocardium showing 1) contrac- 
tile reserve on dobutamine echocardiography, 2) viability on positron 
emission tomography (PET), and 3) viability on positron emission 
tomography with perfusion-metabolism ismatch. 
NS). Th-, mean number of dyrfunctional segments with con- 
tractile reserve in these two ca’egories of patients was 4 ? 3 
and 3 2 2/patient, respectively (p = NS). 
Positran emission tomographic fiodii and correlation 
with dobutamioe-induced conh-actile reserve. In 10 study 
patients, part of the left ventricle (one to two segments) was 
not included within ‘he field of view of the positron emission 
tomographic scanner because of gross cardiomegaly. By using 
predefined viability criteria on positron emission tomography, 
viable dysfunctional myocardium, ranging from 1 to 16 seg- 
ments, was identified in all study patients. Viable dysfunctional 
segments with perfusion-metabolism mismatch were present in 
40 patients (range 1 to 9 segments; mean [tSD] 2 2 Upatient). 
Discussion 
Qn comparison of the two imaging modalities examined in 
this study, there were significanrly more patients with viable 
dysfunctional myocardium identified on positron emission 
tomography (60 of 60) than patients with dysfunctional myo- 
cardium that demonstrated contractile reserve on dobutamine 
echocardiography (52 of 60, p = 0.01). The mean number of 
dysfunctional segments/patient considered viable on positron 
emission tomography (8 ? 4) was also significantly higher than 
the mean number of segments with dobutamine-induced con- 
tractile enhancement (4 2 2, p = 0.001). The relative extent of 
myocardial viability on positron emission tomography and 
dobutamine echocardiography is presented in Figure 1. The 
amount of dysfunctional myocardium with contractile reserve 
appeared to compare best with that of viable dysfunctional 
myocardium astiated with a pattern of perfusion-metabolism 
mismatch on positron emission tomography. 
In patients with left ventricular dysfunction secondary to 
coronary artery disease, positron emission tomography has 
detected the presence of stunned myocardium (8) and pre- 
dicted improvement in regional left ventricular function after 
revascularization in patients with hibernating myocardium 
(4.10). The presence of hibernating tissue has been shown 
(11,12) to be associated with improved survival and ameliora- 
tion of heart failure symptoms after adequate revasculariza- 
tion. Although the true reference standard for verifying the 
presence of viable dysfunctional myocardium comes from 
histologic examination (13) or documentation of improved 
regional wall motion after revascularization (l), positron emis- 
sion tomography is currently the best available modality for 
prospectively identifying such viability before revasculariza- 
tion. However, positron emission tomographic facilities are not 
widely available for general use because of their high operating 
costs. 
The mean number of viable dysfunctional segments/patient . 
Dobutamine stress echocardiography has been demon- 
strated to be a useful and safe imaging modality for the 
diagnosis and localization of functionally significant coronary 
artery disease (14-18). Recently, echocardiography during 
relatively low dose dobutamine infusion has been used to 
detect both stunned myocardium after myocardial infarction 
(19.20) acd hibernating myocardium in patients with chronic 
ischemic left ventricular dysfunction (3-6,21). In these am- 
texts, dobutamine has been shown to enhance contractility in 
dysfunctional but viable myocardium, hence unmasking its 
contractile reserve. 
on posrtron enusslon tomography was similar in patients with 
Canadian Cardiovascular Society class I or II angina symptoms 
(9 2 3) and those with class III or IV symptoms (8 + 4, p = 
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There are many potential advantages of the use of dobut- patients had myocardial segments that showed a contractile 
amine echocardiography in assessment of myocardial viability. 
Echocardiography is a widely available and relatively low cost 
response only with the dobutamine dose of lo-ttg/kg per min. 
imaging modality. The use of dobutamine has been shown to 
A biphasic response to dobutamine has been reported to be 
predictive for recovery of contractile function after revascular- 
be safe in patients with coronary artery disease (22). Viability 
data obtained during low dose infusion can complement 
ization. In a study by Afridi et al. (4), although most segments 
subsequent findings during higher dose stages that provide 
showed functional deterioration at doses >2O f@tg per mm, 
deterioration was observed in some segments with doses as low 
information on regional and global systolic performance at as 7.5 Ilgncg per mm. Thus, when dobutamine infusion is used 
maximal cardiovascular stress. In patients with significant to assess myocardbl viability in such patients, the sensitivity of 
myocardial dysfunction at rest, echocardiography during do- the method is maximued by performance of repeated wall 
butamine infusion is also an alternative to exercise testing, motion assessment at m,dtiple stages as the infusion rate is 
which is often limited by poor exercise. capacity. slowly increased. 
Another strength of the use of inotrope-enhanced contrac- 
tile reserve as a marker of viability in dysfunctional zryocar- 
dium is that it directly demonstrates improved contractility and 
thus provides an indication of potential functional gains after 
successful revascularixation. Other indexes of viability such as 
metabolic activity, myocardial perfusion and cell membrane 
integrity may potentially identify patchy areas of viable tissue 
existing within a predominantly nonviable myocardial region. 
In a study by Amese et al. (U), 43% of akinetic segments with 
no wall motion improvement after administration of dobut- 
amine were judged to be viable on thallium-201 reinjection 
single-photon emission computed tomography: however, only 
18% of these showed recovery of contractile function after 
revascularization. 
Mechanisms. Previous studies examining the histology of 
chronic hibernating myocardium obtained from intraoperative 
biopsy have demonstrated marked cellular changes including 
cellular swelling, replacement of myofibrillar tissue by glycogen 
and loss of sarcoplasmic reticulum (13,24-Z). These findings 
suggest the possibility of a regression phenomenorrin asynergic 
but viable myocardial regions in patients with chronic myocar- 
dial ischemia. Maes et al (24) found that these “dedifferenti- 
ated” regions showed significant recovery of wall motion after 
revascularization. In the present study, disruption of contrac- 
tile structure in regions of viable dysfunctional myocardium 
might have partly explained the relatively limited exten. of 
dobutamine-induced contractile enhancement in comparison 
with viability findings on positron emission tomography. 
In the present study, dysfunctional segments that had 
relative F-18 fluorodeoxyglucose uptake >50% on positron 
emission tomography were regarded as viable. With the use of 
this criterion, clinically relevant viability may have been over- 
estimated and some segments considered viable may not have 
been capable of improving contractility after revascularization. 
Although the induction of contractile enhancement by dobut- 
amine has been proposed as a marker of viability, a lack of 
response does not necessarily imply a complete absence of 
viable myocardium. Furthermore, the relatively low incidence 
of contractile reserve induced by dobutamine in dysfunctional 
segments may be compensated for by the potentially higher 
specificity of dobutamine in predicting recovery in contractile 
function after revascularization. The number of dyshntctional 
segments with contractile reserve as assemed by dobutamine 
appeared to correlate less closely with the number of all viable 
dysfunctional segments assessed by positron emission tomog- 
raphy than with the number of such segments associated with 
a pattern of perfusion-metabolism mismatch (Fig. 1). Such 
mismatch has been shown (11,12) to be a marker of hibemat- 
ing myocardium and predictive of favorable outcome after 
revascularization. 
Tethering of a myocardial segment from adjacent tissue 
may influence the assessment of contractile response during 
inotropic stimulation. To limit the impact of tethering, previ- 
ous investigators (21) required wall motion improvement in 
two contiguous segments for the diignosis of contractile 
reserve. However, this criterion may potentially reduce the 
sensitivity of detection. In the present study, the effect of 
tethering was reduced by observing changes in myocardial 
thickening, which is less susceptible to influences from adja- 
cent segments Beduse most study patients had significant left 
ventricular dysfunction, tethering from adjacent normal or 
hypcrdynamic segments was unlikely to have had a major 
impact on the overall tindings. In contrast tethering from 
adjacent nonviable dysfunctional segments might have reduced 
the degree of, or even abolished, any contractile reserve 
detectable during dobutamine infuskm, hence conmhting to 
the relatively limited inotropic response observed in dysfunc- 
tional segments This possibility was illustrated by the only 
moderate improvement in the overall wall motion score index 
between baseline and the end of the infusion of low dose 
dobt$amine. 
In patients with severe coronary artery disease such as those 
in this study, administration of dobutamine, even in relatively 
low doses, can sometimes precipitate myocardial ischemia. As 
shown in this study, both the heart rate and the heart rate- 
blood pressure double-product were significantly higher than 
at baseline at the end of the IO-&kg per mitt dobutamine 
infusion stage. In total, myocardial ischemia was evident in 17 
patients during administration of dobutamine. However, 22 
l.imiEatioas of the study. Although the method of wall 
motion analysb adopted in this study has been shown to be 
reproducible (27), it uses s&jeuive visual assessment. Because 
wall motion augmentation during dobutamine infusion can 
o&en be subtle and minor on transthoracic echocardiigaphy, 
thii method of detection may be relatively insensitive. Patients 
in this study were not screened for echogenicity before enroll- 
ment. During image acquisition, endocardial detlnition might 
haw been s&optimal in some segments and underestimation 
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of ~ntractile reserve by the reporters could not be excluded. 
Advances in echocardiography in areas such as Doppler myo- 
cardial tissue imaging (28,29) and improvement in endocardial 
definition using contrast enhancement (30,31) may improve 
this technique in the future. With transesophageal echocardi- 
ography, the presence of dobutamine-induced contractile re- 
serve has been reported to have positive and negative predic- 
ttve accuracy of 81% and 97%, respectively. in detecting 
viability on positron emission tomography using F-18 fluoro- 
deoxyglucose alone (3). Magnetic resonance imaging, which is 
also being investigated for assessment of myocardial viability 
(3233) may potentially be applied to detection of contractile 
reserve (6). 
To optimize endocardizi definition so that myocardial 
thickening could be better appreciated, certain minor off-axis 
modifications were occasionrAy necessary during echocardio- 
graphic image acquisition. In a small proportion of studies, 
segments acquired at ditferent stages of the dobutamine infu- 
sion may not have been imaged from identical views and, 
hence, may not have been strictly comparable. Furthermore, 
some segments demonstrated areas of nonhomogeneous wall 
motion and tracer uptake. Their wag motion scores and tracer 
uptake grades were reported as the average estimate for the 
segment. 
Interpretation of findings from this study and their appli- 
cation m the clinical setting are limited by the lack of follow-up 
data on contractile function in patients who underwent revas- 
cularixation, which is the true reference standard for evaluat- 
ing viability assessment by noninvasive imaging modalities. The 
present study suggests that dysfunctional myocardial regtons 
that demonstrate definite contractile enhancement during da- 
butamine infusion are likely to contain a sign&ant number of 
viable myocytes that may potentially improve their contractile 
function after revasctdarization. However, the absence of an 
inotropic response does not completely exclude the possible 
presence of viable myocardium and potential for postrevascu- 
larkration recovery in contractile function, and other ahema- 
tive investigations may be necessary. 
Cnueh~sians. In the assessment of myocardial viability, 
contractile reserve can be induced by infusion of a relatively 
low dose of dobutamine that is safe and well tolerated. Because 
doses as low as 10 @g per min can result in significant 
changes in hemodynamic variables, and occasionally myocar- 
dial ischemia, repeated wall motion assessment should be 
performed at multiple stages as the infusion rate is slowly 
&teased to maximii the iikeliiood of demonstrating con- 
traetile improvement after dobutamine. These patients with 
moderately severe chronic ischemic left ventricular dysfunc- 
tion, had fewer dysfunctional myocardial segments with dobu- 
tamine-induced contractile reserve than dysfunctional myocar- 
dial segments defined as viable on positron emission 
tomography. However, the extent of dysfunctional myocar- 
ditmt with contracti.le reserve appeared to correlate more 
closely with that of viable dysfunctional myocardium associ- 
ated wiih a pattern of perfusion-metabolism mismatch on 
positron emission tomography. 
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